CAS 2232180-74-2

Quinoline, 3-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]-7-methoxy-

Description:

Quinoline, 3-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]-7-methoxy- is a synthetic organic compound that belongs to the quinoline family, characterized by a bicyclic structure containing a benzene ring fused to a pyridine ring. This compound features a methoxy group at the 7-position and a 1,2,4-oxadiazole moiety substituted at the 3-position, which contributes to its potential biological activity. The presence of the bromophenyl group enhances its lipophilicity and may influence its interaction with biological targets. Quinoline derivatives are known for their diverse pharmacological properties, including antimicrobial, antimalarial, and anticancer activities. The specific arrangement of functional groups in this compound can affect its solubility, stability, and reactivity, making it of interest in medicinal chemistry and drug development. Additionally, the compound's unique structure may allow for further modifications to optimize its therapeutic efficacy or to explore new applications in various fields, including materials science and agrochemicals.

Formula: C₁₈H₁₂BrN₃O₂

Synonyms:

• BT173
• Quinoline, 3-[3-(4-bromophenyl)-1,2,4-oxadiazol-5-yl]-7-methoxy-

BT173

CAS: 2232180-74-2

BT173 is a novel inhibitor of homeodomain interacting protein kinase 2 (HIPK2 ), attenuating renal fibrosis through suppression of the TGF-ß1/Smad3 pathway.

Formula: C₁₈H₁₂BrN₃O₂

Purity: 98.247%

Color and Shape: Solid

Molecular weight: 382.21

Ref: TM-T9953

BT173

CAS: 2232180-74-2

BT173

Purity: ≥95%

Molecular weight: 382.21g/mol

Ref: 54-BUP01206